MicroRNA-337-3p impedes breast cancer progression by targeting cyclin-dependent kinase 1.

Abstract

MicroRNAs (miRNAs/miRs) function as key regulators in breast cancer (BC). The present study aimed to verify the function and molecular regulation of miR-337-3p in BC cells. Bioinformatics analysis was performed to screen key genes and miRNAs associated with BC. Reverse transcription-quantitative PCR and western blot analyses were performed to detect RNA and protein expression levels. Cell Counting Kit-8, BrdU and cell adhesion assays, and flow cytometric analysis were performed to assess the biological behaviors of BC cells. The dual-luciferase reporter, RNA pull-down assays, and Pearson's correlation analysis were performed to determine the association between miRNAs and mRNAs. Bioinformatics analysis revealed that miR-337-3p and cyclin-dependent kinase 1 (CDK1) acted as key regulators in BC. In addition, miR-337-3p was expressed at low levels in BC cells and tissues, which suppressed BC progression. CDK1 expression was upregulated in BC cells and tissues, which was associated with increased cell proliferation and adhesion, as well as decreased apoptosis in BC. Notably, miR-337-3p targeted CDK1 to inhibit BC cell progression. Taken together, the results of the present study suggest that miR-337-3p plays a tumor-suppressive role in BC by targeting CDK1.

• Authors: Shuxin Kong, Jianyang Liu, Bin Zhang, Feng Lv, Yang Yu, Tao Qin
• Journal: Oncology letters (Oncol Lett) Vol. 23 Issue 1 Pg. 15 (Jan 2022) ISSN: 1792-1082 [Electronic] Greece
• PMID: 34820014 (Publication Type: Journal Article)
• Copyright: Copyright: © Kong et al.